These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
346 related items for PubMed ID: 16681904
1. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain]. Guan XZ, Liu YN, Luo YP, She DY, Lu SJ, Zhou G, Chen LA. Zhonghua Yi Xue Za Zhi; 2006 Mar 07; 86(9):600-4. PubMed ID: 16681904 [Abstract] [Full Text] [Related]
2. [A new member of CMY type cephalosporinase prevailing in Escherichia coli]. Guan XZ, Liu YN, Luo YP, She DY, Zhou G, Chen LA, Xu YP. Zhonghua Yi Xue Za Zhi; 2004 Nov 17; 84(22):1872-5. PubMed ID: 15631796 [Abstract] [Full Text] [Related]
3. [DHA-1 type cephalosporinase accompanied with SHV-12 prevailed in clinical isolates of Klebsiella pneumoniae]. Guan XZ, Liu YN, Luo YP, She DY, Zhou G, Chen LA, Xu YP. Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul 17; 28(7):475-8. PubMed ID: 16115398 [Abstract] [Full Text] [Related]
4. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, Simor AE, Paton S, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. FEMS Microbiol Lett; 2007 May 17; 270(2):265-71. PubMed ID: 17326753 [Abstract] [Full Text] [Related]
5. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. Haldorsen B, Aasnaes B, Dahl KH, Hanssen AM, Simonsen GS, Walsh TR, Sundsfjord A, Lundblad EW. J Antimicrob Chemother; 2008 Oct 17; 62(4):694-702. PubMed ID: 18583329 [Abstract] [Full Text] [Related]
6. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin]. Demirbakan H, Midilli K, Oğünç D, Ozen N, Ongüt G, Dağlar D, Mutlu D, Ozhak B, Colak D. Mikrobiyol Bul; 2008 Oct 17; 42(4):545-51. PubMed ID: 19149075 [Abstract] [Full Text] [Related]
7. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. Jørgensen RL, Nielsen JB, Friis-Møller A, Fjeldsøe-Nielsen H, Schønning K. J Antimicrob Chemother; 2010 Mar 17; 65(3):460-4. PubMed ID: 20097787 [Abstract] [Full Text] [Related]
8. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Oteo J, Delgado-Iribarren A, Vega D, Bautista V, Rodríguez MC, Velasco M, Saavedra JM, Pérez-Vázquez M, García-Cobos S, Martínez-Martínez L, Campos J. Int J Antimicrob Agents; 2008 Dec 17; 32(6):534-7. PubMed ID: 18775649 [Abstract] [Full Text] [Related]
15. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins. Paltansing S, Kraakman M, van Boxtel R, Kors I, Wessels E, Goessens W, Tommassen J, Bernards A. Microb Drug Resist; 2015 Feb 17; 21(1):7-16. PubMed ID: 25188329 [Abstract] [Full Text] [Related]
16. [Study on the genetic structure and transmission mechanism of a plasmid-mediated AmpC beta-lactamase]. Lu WX, Wei ZQ, Yu YS, Chen YG, Li LJ. Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3043-7. PubMed ID: 16324403 [Abstract] [Full Text] [Related]